What are the precautions for taking meniclothione sulfate

There are many types of bacteria in our daily life, such as Escherichia coli, Shigella dysenteriae, Proteus, etc. Once these bacteria enter the human body, they will cause sepsis, bronchitis, pneumonia and many other diseases. If the treatment method is not correct, the condition will worsen. Micromycin sulfate can effectively treat these diseases. So what are the precautions for micromycin sulfate?

First, what are the precautions for taking metronidazole sulfate? This product is mainly used for respiratory tract, urinary tract, abdominal cavity and trauma infections caused by Gram-negative bacteria such as Escherichia coli, Klebsiella, Proteus, Enterobacter, Serratia, Pseudomonas aeruginosa, etc., and can also be used for sepsis.

Second, usage and dosage: intramuscular injection or intravenous drip after dilution. Adults: Intramuscular injection: 60-80 mg at a time, up to 120 mg if necessary, 2-3 times a day; intravenous drip: 60 mg at a time (2 vials at a time), add to 100 ml of sodium chloride injection and drip at a constant rate, and the drip should be completed within 1 hour. Children: 3-4 mg/kg per body weight, divided into 2-3 doses.

Third, adverse reactions: common hearing loss, tinnitus or a feeling of fullness in the ears (ototoxicity), hematuria, a significant decrease in the frequency of urination or decreased urine volume, loss of appetite, extreme thirst (nephrotoxicity), unsteady gait, dizziness (ototoxicity, vestibular effects), nausea or vomiting (ototoxicity, vestibular effects, nephrotoxicity). 2. Rarely, there may be visual impairment (optic neuritis), dyspnea, drowsiness, extreme weakness (neuromuscular blockade), allergic reactions such as rash, changes in blood count, changes in liver function, gastrointestinal reactions, and pain, nodules, and phlebitis at the injection site. 3. Anaphylactic shock is extremely rare.

What are the precautions for metronidazole sulfate? It should be used with caution in patients with renal insufficiency, abnormal liver function, vestibular function or hearing loss, dehydration, myasthenia gravis or Parkinson's disease and the elderly. The duration of medication should generally not exceed 14 days. If the medication must be continued, the hearing organs and kidney function should be closely monitored. Cross-allergy: patients who are allergic to an aminoglycoside antibiotic such as streptomycin or gentamicin may be allergic to this product. If conditions permit, blood drug concentration should be monitored during treatment and the dosage should be adjusted accordingly. When blood drug concentration cannot be measured, the dosage should be adjusted according to the measured creatinine clearance, especially for patients with impaired renal function, premature infants, newborns, infants or elderly patients, shock, heart failure, ascites or severe dehydration. This product is generally only for intramuscular injection; it can be injected intravenously after dilution; but it should not be injected intravenously to avoid neuromuscular blockade and respiratory depression. . Long-term use of this product may lead to overgrowth of drug-resistant bacteria. .Patients should be given adequate water to reduce renal tubular damage.